IP Library › Assignment 072268/0930
Patent Assignment
Reel/Frame 072268/0930

Assignment of Assignor's Interest

Recorded: 2025-07-25 Pages: 11
Assignor
MEDIGENEBIO CORPORATION
Executed: 2025-06-13
Assignee
GREEN CROSS CORPORATION
107, IHYEON-RO 30BEON-GIL, GIHEUNG-GU, YONGIN-SI, GYEONGGI-DO, 446-855, KOREA, REPUBLIC OF
Covered Properties (4)
Composition and Formulation Comprising Recombinant Human Iduronate-2-Sulfatase and Preparation Method Thereof
Patent: 9,206,402 →
Application: 14/128,918 →
Publication: US 2014/0242059
Composition and Formulation Comprising Recombinant Human Iduronate-2-Sulfatase and Preparation Method Thereof
Patent: 9,249,397 →
Application: 14/809,856 →
Publication: US 2015/0320843
Composition and Formulation Comprising Recombinant Human Iduronate-2-Sulfatase and Preparation Method Thereof
Patent: 9,896,672 →
Application: 15/184,406 →
Publication: US 2016/0326504
Composition and Formulation Comprising Recombinant Human Iduronate-2-Sulfatase and Preparation Method Thereof
Application: 15/812,851 →
Publication: US 2018/0112199
Related Assignments (2)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 24, 2013
From: JIN, THONG-GYU; CHUNG, YO KYUNG; PAIK, SANG HOON; PARK, YOO CHANG
To: GREEN CROSS CORPORATION; MEDIGENEBIO CORPORATION
Reel/Frame 031845/0094 →
Corrective Assignment to Correct the Docket Number Previously Recorded on Reel 031845 Frame 0094. Assignor(S) Hereby Confirms the Q208623. Jan 6, 2014
From: JIN, THONG-GYU; CHUNG, YO KYUNG; PAIK, SANG HOON; PARK, YOO CHANG
To: GREEN CROSS CORPORATION; MEDIGENEBIO CORPORATION
Reel/Frame 031923/0377 →